AVCRF vs MCUJF
Avricore Health Inc. and Medicure Inc., side by side — 8 fiscal years reported in CAD, drawn from SEC filings.
Most recent reported year
| Metric | AVCRF | MCUJF |
|---|---|---|
| Revenue | CAD 4.7M | CAD 21.9M |
| Net income | CAD -668,977 | CAD -1.0M |
| Gross margin | 40.4% | 59.7% |
| Net margin | −14.4% | −4.7% |
| Return on equity | −33.6% | −5.1% |
| Diluted EPS | −CAD 0.01 | −CAD 0.10 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | CAD 823,521 | CAD 638,000 |
| Equity | · | · |
| Net debt / equity | · | · |
| Current ratio | · | 1.89× |
| Revenue CAGR 5y | · | 1.7% |
| Profit CAGR 5y | · | · |
MCUJF bills 4.7× the revenue of AVCRF, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
8 years side by side
| Fiscal year | AVCRF | MCUJF |
|---|---|---|
| FY2024 | CAD 4.7M | CAD 21.9M |
| FY2023 | CAD 3.5M | CAD 21.7M |
| FY2022 | CAD 1.8M | CAD 23.1M |
| FY2021 | CAD 122,808 | CAD 21.7M |
| FY2020 | CAD 33,030 | CAD 11.6M |
| FY2018 | CAD 827,961 | CAD 29.1M |
| FY2017 | CAD 1.6M | CAD 27.1M |
| FY2016 | CAD 2.5M | CAD 29.3M |
Bottom line
| Fiscal year | AVCRF | MCUJF |
|---|---|---|
| FY2024 | CAD -668,977 | CAD -1.0M |
| FY2023 | CAD -701,215 | CAD -922,000 |
| FY2022 | CAD -818,228 | CAD 1.4M |
| FY2021 | CAD -1.7M | CAD -727,000 |
| FY2020 | CAD -1.2M | CAD -6.8M |
| FY2018 | CAD -4.1M | CAD 3.9M |
| FY2017 | CAD -2.7M | CAD 43.4M |
| FY2016 | CAD -2.6M | CAD 27.0M |
8 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | −CAD 17,248,605 | MCUJF |
| FY2023 | −CAD 18,209,753 | MCUJF |
| FY2022 | −CAD 21,296,626 | MCUJF |
| FY2021 | −CAD 21,621,192 | MCUJF |
| FY2020 | −CAD 11,576,970 | MCUJF |
| FY2018 | −CAD 28,281,039 | MCUJF |
| FY2017 | −CAD 25,515,917 | MCUJF |
| FY2016 | −CAD 26,842,867 | MCUJF |
MCUJF has reported the higher revenue in every one of these 8 fiscal years. The gap has narrowed since the earliest year compared.
8 of 11 comparable fiscal years — a year missing data on either side is not counted.
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | −9.6 pp | MCUJF |
| FY2023 | −15.9 pp | MCUJF |
| FY2022 | −52.2 pp | MCUJF |
| FY2021 | −1387.6 pp | MCUJF |
| FY2018 | −513.1 pp | MCUJF |
| FY2017 | −329.3 pp | MCUJF |
| FY2016 | −198.2 pp | MCUJF |
MCUJF has kept the higher net margin in every one of these 7 fiscal years.
7 of 10 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
AVCRF's net margin has been more volatile than MCUJF's over the 7 comparable fiscal years — 463.8 percentage points of standard deviation against 59.5.
7 of 10 comparable fiscal years — a year missing data on either side is not counted.
Year by year
MCUJF led in net margin in every one of the 7 comparable fiscal years — a structural lead, not a recent swing.
7 of 10 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
AVCRF's return on equity has been more volatile than MCUJF's over the 6 comparable fiscal years — 76.4 percentage points of standard deviation against 51.6.
6 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
MCUJF led in return on equity in every one of the 6 comparable fiscal years — a structural lead, not a recent swing.
6 of 11 comparable fiscal years — a year missing data on either side is not counted.